Search research articles
Contact Us
Filters
Showing results (91-100 of 107) with videos related to
Page
of 11
Sort By:
Nature Medicine
|
December 29, 2009
A key role for orexin in panic anxiety
Philip L Johnson, William Truitt, Stephanie D Fitz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 2, 2021
Long-term clinical, MRI, and cognitive follow-up in a large cohort of pathologically confirmed, predominantly tumefactive multiple sclerosis
Alicja Kalinowska-Lyszczarz, Jan-Mendelt Tillema, W Oliver Tobin, et al.
Frontiers in Neuroscience
|
January 9, 2019
Orexin Depolarizes Central Amygdala Neurons via Orexin Receptor 1, Phospholipase C and Sodium-Calcium Exchanger and Modulates Conditioned Fear
Erik T Dustrude, Izabela F Caliman, Cristian S Bernabe, et al.
Translational Psychiatry
|
August 16, 2018
PSD95 and nNOS interaction as a novel molecular target to modulate conditioned fear: relevance to PTSD
L- P Li, E T Dustrude, M M Haulcomb, et al.
Alcoholism, Clinical and Experimental Research
|
March 12, 2014
Alcohol-preferring rats show decreased corticotropin-releasing hormone-2 receptor expression and differences in HPA activation compared to alcohol-nonpreferring rats
Weidong Yong, John Paul Spence, Robert Eskay, et al.
Frontiers in Pharmacology
|
June 27, 2017
Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation
Pascal Bonaventure, Christine Dugovic, Brock Shireman, et al.
Pharmacology, Biochemistry, and Behavior
|
October 18, 2015
Pharmacological depletion of serotonin in the basolateral amygdala complex reduces anxiety and disrupts fear conditioning
Philip L Johnson, Andrei Molosh, Stephanie D Fitz, et al.
Plos One
|
March 26, 2014
Persistent urinary podocyte loss following preeclampsia may reflect subclinical renal injury
Wendy M White, Angelica T Garrett, Iasmina M Craici, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 14, 2015
A selective orexin-1 receptor antagonist attenuates stress-induced hyperarousal without hypnotic effects
Pascal Bonaventure, Sujin Yun, Philip L Johnson, et al.
The Journal of Biological Chemistry
|
January 19, 2020
The small molecule GAT1508 activates brain-specific GIRK1/2 channel heteromers and facilitates conditioned fear extinction in rodents
Yu Xu, Lucas Cantwell, Andrei I Molosh, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 107) with videos related to
Sort By:
Page
of 11
Nature Medicine
|
December 29, 2009
A key role for orexin in panic anxiety
Philip L Johnson, William Truitt, Stephanie D Fitz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 2, 2021
Long-term clinical, MRI, and cognitive follow-up in a large cohort of pathologically confirmed, predominantly tumefactive multiple sclerosis
Alicja Kalinowska-Lyszczarz, Jan-Mendelt Tillema, W Oliver Tobin, et al.
Frontiers in Neuroscience
|
January 9, 2019
Orexin Depolarizes Central Amygdala Neurons via Orexin Receptor 1, Phospholipase C and Sodium-Calcium Exchanger and Modulates Conditioned Fear
Erik T Dustrude, Izabela F Caliman, Cristian S Bernabe, et al.
Translational Psychiatry
|
August 16, 2018
PSD95 and nNOS interaction as a novel molecular target to modulate conditioned fear: relevance to PTSD
L- P Li, E T Dustrude, M M Haulcomb, et al.
Alcoholism, Clinical and Experimental Research
|
March 12, 2014
Alcohol-preferring rats show decreased corticotropin-releasing hormone-2 receptor expression and differences in HPA activation compared to alcohol-nonpreferring rats
Weidong Yong, John Paul Spence, Robert Eskay, et al.
Frontiers in Pharmacology
|
June 27, 2017
Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation
Pascal Bonaventure, Christine Dugovic, Brock Shireman, et al.
Pharmacology, Biochemistry, and Behavior
|
October 18, 2015
Pharmacological depletion of serotonin in the basolateral amygdala complex reduces anxiety and disrupts fear conditioning
Philip L Johnson, Andrei Molosh, Stephanie D Fitz, et al.
Plos One
|
March 26, 2014
Persistent urinary podocyte loss following preeclampsia may reflect subclinical renal injury
Wendy M White, Angelica T Garrett, Iasmina M Craici, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 14, 2015
A selective orexin-1 receptor antagonist attenuates stress-induced hyperarousal without hypnotic effects
Pascal Bonaventure, Sujin Yun, Philip L Johnson, et al.
The Journal of Biological Chemistry
|
January 19, 2020
The small molecule GAT1508 activates brain-specific GIRK1/2 channel heteromers and facilitates conditioned fear extinction in rodents
Yu Xu, Lucas Cantwell, Andrei I Molosh, et al.
Page
of 11